Cedric Bogaert | Chief Executive Officer
myNEO Therapeutics

Cedric Bogaert is co-founder of myNEO, where he leads the development of AI-driven platforms for immunogenicity prediction and next-generation biologics design. Recognized as a Forbes-listed innovator, he has driven multiple high-impact biopharma collaborations, including work with CureVac, and contributed to advancing three therapeutic assets into the clinic by 2025. His work focuses on translating cutting-edge computational approaches into scalable, real-world applications that reshape how immunogenicity risk is assessed and engineered out early in drug development.